Advertisement
Organisation › Details
Ysios Capital Partners SGECR S.A.
Ysios Capital is a leading Spanish venture capital firm that provides private equity financing to early- and mid-stage, highly innovative life science companies bringing life-changing treatments to patients, with a focus on indications with high unmet need. Our diverse international team in San Sebastián and Barcelona is driven by science, with the ambition to transform capital into medical breakthroughs. Ysios Capital was founded in 2008 and has over $450 million in assets under management through its three funds. *
Name: Ysios Capital Partners
Web/URL: www.ysioscapital.com
Contact:
Address: travessera de gràcia, 11 floor 8th 08021 Barcelona, Catalonia, Spain
Telephone: +34-93-5173545
General contact: ysios@ysioscapital.com
Profile:
Ysios Capital is a leading Spanish venture capital firm that provides private equity financing to early- and mid-stage human healthcare and life science companies with a special focus on pharmaceuticals, diagnostics and medical devices.
Founded in 2008, Ysios Capital has € 125 million in assets under management distributed over two funds. The second fund has a target size of € 100 million and will remain open to new investors until December 2015.
Industry: Venture capital, life sciences
Products/Services: Investment
Established: 2008
Employees: 11
The organisation submitted the information to [LSE] on 18 August 2015.
Start | 2008-01-01 established | |
Group | Ysios Capital (Group) | |
Industry | venture capital | |
Industry 2 | LIFE SCIENCES | |
Person | Jean-Mairet, Joël (Ysios Capital 201206) | |
Region | Barcelona | |
Country | Spain (España) | |
Street | 11 Travessera de Gràcia 8th Floor | |
City | 08021 Barcelona | |
Tel | +34-93-517-3545 | |
Address record changed: 2021-04-28 | ||
Basic data | Employees | B: 11 to 50 (2015-08-18) |
Currency | EUR | |
Annual sales | 450,000,000 (assets, managed (2022) 2022-03-04) | |
* Document for »About Section«: Ysios Capital. (3/4/22). "Press Release: Ysios Capital Strengthens Its Team with the Appointment of Thomas Harth as Principal Thomas Harth". San Sebastián & Barcelona. | ||
Record changed: 2024-03-23 |
Advertisement
More documents for Ysios Capital (Group)
- [1] Tagworks Pharmaceuticals B.V.. (6/22/23). "Press Release: Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics". Nijmegen & Boston, MA....
- [2] Ysios Capital. (3/4/22). "Press Release: Ysios Capital Strengthens Its Team with the Appointment of Thomas Harth as Principal Thomas Harth". San Sebastián & Barcelona....
- [3] NorthSea Therapeutics B.V.. (12/17/21). "Press Release: NorthSea Therapeutics Completes US$80 Million Series C Fundraising to Advance Clinical Programs in Metabolic Disorders". Amsterdam....
- [4] VarmX B.V.. (7/8/20). "Press Release: VarmX Raises €32 million in Series B Financing to Develop Innovative Reversal Agent for the Treatment and Prevention of Severe Bleeding in Patients on Oral Anticoagulants". Leiden....
- [5] Ysios Capital. (9/24/18). "Press Release: Ysios Capital Strengthens Its Team with the Appointment of Guillem Laporta as Principal and Two New Venture Partners". Barcelona....
- [6] Xeltis AG. (11/15/17). "Press Release: Xeltis Closes €45 Million in Oversubscribed Series C Financing to Advance Aortic and Pulmonary Valve Programs". Zurich & Eindhoven....
- [7] BioClin Therapeutics, Inc.. (3/22/17). "Press Release: BioClin Therapeutics, Inc., Raises $30 Million in Series B Financing Led by Sofinnova Ventures and Ysios Capital". San Ramon, CA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top